Naringin Attenuates Cerebral Ischemia-Reperfusion Injury Through Inhibiting Peroxynitrite-Mediated Mitophagy Activation. 2018

Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Room 110, 1/F, No.10, Sassoon Road, Pokfulam, Hong Kong, SAR, China.

Excessive autophagy/mitophagy plays important roles during cerebral ischemia-reperfusion (I/R) injury. Peroxynitrite (ONOO-), a representative reactive nitrogen species, mediates excessive mitophagy activation and exacerbates cerebral I/R injury. In the present study, we tested the hypothesis that naringin, a natural antioxidant, could inhibit ONOO--mediated mitophagy activation and attenuate cerebral I/R injury. Firstly, we demonstrated that naringin possessed strong ONOO- scavenging capability and also inhibited the production of superoxide and nitric oxide in SH-SY5Y cells exposed to 10 h oxygen-glucose-deprivation plus 14 h of reoxygenation or ONOO- donor 3-morpholinosydnonimine conditions. Naringin also inhibited the expression of NADPH oxidase subunits and iNOS in rat brains subjected to 2 h ischemia plus 22 h reperfusion. Next, we found that naringin was able to cross the blood-brain barrier, and naringin decreased neurological deficit score, reduced infarct size, and attenuated apoptotic cell death in the ischemia-reperfused rat brains. Furthermore, naringin reduced 3-nitrotyrosine formation, decreased the ratio of LC3-II to LC3-I in mitochondrial fraction, and inhibited the translocation of Parkin to the mitochondria. Taken together, naringin could be a potential therapeutic agent to prevent the brain from I/R injury via attenuating ONOO--mediated excessive mitophagy.

UI MeSH Term Description Entries
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
November 2020, Free radical biology & medicine,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
January 2021, Translational neuroscience,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
May 2023, Experimental cell research,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
September 2023, Experimental cell research,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
January 2020, Current neurovascular research,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
December 2000, American journal of physiology. Cell physiology,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
January 2015, Oxidative medicine and cellular longevity,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
January 2020, Free radical biology & medicine,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
May 2021, European journal of pharmacology,
Jinghan Feng, and Xingmiao Chen, and Shengwen Lu, and Wenting Li, and Dan Yang, and Weiwei Su, and Xijun Wang, and Jiangang Shen
March 2023, Journal of geriatric cardiology : JGC,
Copied contents to your clipboard!